Ankerhold, Jakob http://orcid.org/0000-0002-1524-9445
Giese, Sebastian http://orcid.org/0000-0001-6215-5743
Kolb, Philipp http://orcid.org/0000-0001-7935-217X
Maul-Pavicic, Andrea
Voll, Reinhard E.
Göppert, Nathalie
Ciminski, Kevin http://orcid.org/0000-0001-5397-7497
Kreutz, Clemens http://orcid.org/0000-0002-8796-5766
Lother, Achim
Salzer, Ulrich
Bildl, Wolfgang
Welsink, Tim
Morgenthaler, Nils G.
Grawitz, Andrea Busse
Emmerich, Florian
Steinmann, Daniel
Huzly, Daniela
Schwemmle, Martin http://orcid.org/0000-0002-2972-6855
Hengel, Hartmut http://orcid.org/0000-0002-3482-816X
Falcone, Valeria http://orcid.org/0000-0003-1180-8737
Article History
Received: 9 September 2021
Accepted: 22 August 2022
First Online: 26 September 2022
Competing interests
: T.W. and N.G.M are employees at InVivo BioTech Services, a biotechnology company producing antibodies and proteins, including SARS-CoV-2 antigens. The remaining authors declare no competing interests.